scispace - formally typeset
J

Joseph N. Marcus

Researcher at Creighton University

Publications -  23
Citations -  2199

Joseph N. Marcus is an academic researcher from Creighton University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 13, co-authored 23 publications receiving 2177 citations.

Papers
More filters
Journal ArticleDOI

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

TL;DR: Immunohistochemically detected p53 protein accumulation was an independent marker of shortened survival and was seen more often in familial than in sporadic carcinomas, suggesting a correlation between p53protein accumulation and p53 gene mutation.
Journal ArticleDOI

Hereditary breast cancer : pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

TL;DR: The purpose of this investigation was to determine if there are pathobiologic differences between BRCA1‐related and BRCa2‐related hereditary breast cancer (HBC) and non‐HBC.
Journal ArticleDOI

Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux.

TL;DR: Clinically, bile diversion by suprapapillary Roux-en-Yduodenojejunostomy alleviates symptoms of duodenogastric reflux disease without being ulcerogenic (in the presence of normal gastric secretion) or prolonging gastric emptying.
Journal ArticleDOI

Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II).

TL;DR: It is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of the hereditary nonpolyposis syndromes syndrome, and a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions.
Journal ArticleDOI

Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)

TL;DR: Clinician must recognize clinical findings and family history typical of HNPCC, and third-party carriers must become more responsive to the costly surveillance measures required for otherwise healthy patients.